- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06871462
Implementation Strategies for Self-Measured Blood Pressure Monitoring in Racially and Ethnically Diverse Populations (INSPIRED)
Study Overview
Status
Conditions
Intervention / Treatment
- Behavioral: BP monitor use training and app training
- Behavioral: SMS reminders to take blood pressure
- Behavioral: Education about self-management of hypertension
- Behavioral: Educational text messages that encourage seeking support from a support person
- Behavioral: Group classes
- Behavioral: Online patient portal enrollment and training
- Behavioral: Involvement of caregiver or support person
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
San Francisco, California, United States, 94110
- Zuckerberg San Francisco General Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 18 years old/order
- Any sex or gender
- Any race or ethnicity
- Must be receiving primary care at any of the six enrolled clinics
- Have uncontrolled hypertension (two clinic BP readings ≥140/90 mmHg within the previous 18 months)
- Can read and write English, Spanish, or Cantonese
- Be able to provide consent
- Must own a cell phone that receives SMS or text messages
Exclusion Criteria:
Those with conditions that might complicate remote BP monitoring:
- Pregnancy (and 12 months postpartum)
- Acute myocardial infarction or stroke in the last 12 months
- End-stage renal disease on dialysis
- Stage D heart failure
- Active treatment for cancer (except for nonmelanoma skin cancers)
- Pacemaker use
- Those with dementia, in hospice care, or with serious behavioral health conditions impeding participation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Low-Intensity (Usual Care)
Patient level: training on how to use a blood pressure (BP) monitor and online patient portal (ex. MyChart), receive reminders to take their BP at home, receive educational messages, and access to language-concordant educational materials. Clinic level: training on standardized workflows and EHR tools, audit and feedback |
Patients will be taught how to use a BP monitor, along with the accompanying mobile app to view their readings.
Patients will receive reminders via SMS to take their blood pressure.
One-time training with action planning, access to website with language concordant patient education, and educational text messages
Patients will receive training on how to use an online patient portal.
If they are not yet enrolled in an online patient portal and would like to be, they will also be enrolled into one.
|
|
Experimental: High-Intensity
Patient level: In addition to the Low-Intensity Arm strategies, patients will be asked to attend four educational group sessions with other trial patients. Patients will also be asked to involve support persons in their hypertension management. The educational messages that patients receive will also explicitly encourage involvement of a support person. Clinic level: training on standardized workflows and EHR tools, audit and feedback |
Patients will be taught how to use a BP monitor, along with the accompanying mobile app to view their readings.
Patients will receive reminders via SMS to take their blood pressure.
One-time training with action planning, access to website with language concordant patient education, and educational text messages
Educational text messages about behavioral changes that explicitly encourage seeking support from a support person
Patients will be asked to attend in-person or online group education classes on hypertension management
Patients will receive training on how to use an online patient portal.
If they are not yet enrolled in an online patient portal and would like to be, they will also be enrolled into one.
Patients will be asked to involve a caregiver or support person for all activities above, including patient portal proxy access.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in clinic systolic BP
Time Frame: Baseline, 12 months, 18 months
|
Baseline, 12 months, 18 months
|
|
|
BP Control
Time Frame: Monthly (-6 to 18 months)
|
Clinic patients with EHR recorded BP < 140/90
|
Monthly (-6 to 18 months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Home Systolic BP (SBP)
Time Frame: Baseline, 12 months, 18 months
|
Home SBP for enrolled participants
|
Baseline, 12 months, 18 months
|
|
Patient Adoption
Time Frame: 12 months
|
Number of SMBP values per participant
|
12 months
|
|
Patient Activation
Time Frame: Baseline, 12 months
|
Patient Assessment of Chronic Illness Care (PACIC) - Minimum score: 1, Maximum score: 5.
The PACIC is scored by summing participants' responses across all 20 items then dividing by 20, the number of items in the scale.
Thus, scores on the PACIC range from 1 to 5 with higher scores indicating a better outcome (patient's perception of greater involvement in self-management and receipt of chronic care counseling).
|
Baseline, 12 months
|
|
BP Control
Time Frame: Baseline, 12 months, 18 months
|
Enrolled participants with controlled BP based on (a) clinic BP values; (b) home BP values
|
Baseline, 12 months, 18 months
|
|
Clinic adoption
Time Frame: Monthly (-6 to 18 months)
|
Clinic patients with EHR documented patient reported BP
|
Monthly (-6 to 18 months)
|
|
Costs
Time Frame: During trial; 12 months
|
Costs (including time, equipment, consumables) of SMBP monitoring + implementation strategies
|
During trial; 12 months
|
|
Reach
Time Frame: 12 months
|
Percent of participants who actively participate in SMBP monitoring
|
12 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Elaine Khoong, MD, MS, University of California, San Francisco
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 24-42092
- R18HS029817 (U.S. AHRQ Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.